Clinical trial
A Comparative Study on the Incidence of Respiratory Adverse Events Between Esketamine Combined With Remazolam and Traditional Propofol in Pediatric Gastroscopy
NCT07748884 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Comparative Study on the Incidence of Respiratory Adverse Events Between Esketamine Combined With Remazolam and Traditional Propofol in Pediatric Gastroscopy
- Lead sponsor
- Second Affiliated Hospital of Wenzhou Medical University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- August 31, 2026
- Completion date
- December 31, 2026
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adverse respiratory events, children, esketamine, gastroscopy, hypoxemia, remimazolam